| SC 13G/A | 2024-02-14 | Alyeska Investment Group, L.P. | Unity Biotechnology, Inc. | 1,676,818 | 10.0% | EDGAR |
| SC 13G/A | 2023-05-10 | FMR LLC | Unity Biotechnology, Inc. | 600,004 | 4.0% | EDGAR |
| SC 13G | 2023-02-14 | Alyeska Investment Group, L.P. | Unity Biotechnology, Inc. | 1,419,000 | 10.0% | EDGAR |
| SC 13G/A | 2023-02-09 | FMR LLC | Unity Biotechnology, Inc. | 1,363,120 | 9.2% | EDGAR |
| SC 13G/A | 2022-10-11 | FMR LLC | Unity Biotechnology, Inc. | 13,543,215 | 9.7% | EDGAR |
| SC 13G/A | 2022-09-12 | FMR LLC | Unity Biotechnology, Inc. | 13,323,215 | 15.0% | EDGAR |
| SC 13G/A | 2022-02-14 | Venrock Associates VII, L.P. | Unity Biotechnology, Inc. | 2,680,039 | 4.6% | EDGAR |
| SC 13G/A | 2022-02-11 | ARCH Venture Fund VII, L.P. | Unity Biotechnology, Inc. | 10,048,181 | 17.4% | EDGAR |
| SC 13G/A | 2022-02-09 | FMR LLC | Unity Biotechnology, Inc. | 3,106,530 | 5.4% | EDGAR |
| SC 13G/A | 2021-07-01 | BAILLIE GIFFORD & CO | Unity Biotechnology, Inc. | 2,479,068 | 4.5% | EDGAR |
| SC 13G/A | 2021-06-09 | BlackRock Inc. | Unity Biotechnology, Inc. | 2,711,482 | 4.9% | EDGAR |
| SC 13G/A | 2021-02-08 | FMR LLC | Unity Biotechnology, Inc. | 4,583,617 | 8.7% | EDGAR |
| SC 13G/A | 2021-02-02 | ARCH Venture Fund VII, L.P. | Unity Biotechnology, Inc. | 10,048,181 | 19.0% | EDGAR |
| SC 13G | 2021-02-02 | BlackRock Inc. | Unity Biotechnology, Inc. | 2,881,653 | 5.4% | EDGAR |
| SC 13G/A | 2021-01-14 | BAILLIE GIFFORD & CO | Unity Biotechnology, Inc. | 3,803,014 | 7.2% | EDGAR |
| SC 13G | 2021-01-08 | WuXi PharmaTech Healthcare Fund I L.P. | Unity Biotechnology, Inc. | 1,477,987 | 2.8% | EDGAR |
| SC 13G/A | 2020-02-13 | ARCH Venture Fund VII, L.P. | Unity Biotechnology, Inc. | 10,048,181 | 21.9% | EDGAR |
| SC 13G | 2020-02-11 | David Nathaniel E | Unity Biotechnology, Inc. | 2,372,160 | 5.2% | EDGAR |
| SC 13G/A | 2020-02-07 | FMR LLC | Unity Biotechnology, Inc. | 4,850,989 | 10.6% | EDGAR |
| SC 13G/A | 2020-02-03 | BAILLIE GIFFORD & CO | Unity Biotechnology, Inc. | 3,803,014 | 8.3% | EDGAR |